| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3M | -10.5% | -15.3% |
| Cost of Revenue | $884K | +7.3% | -14.3% |
| R&D Expense | $0 | -100.0% | -100.0% |
| SG&A Expense | $1.6M | -26.0% | -29.9% |
| Operating Income | -$1.2M | -129.9% | +34.5% |
| Net Income | $856K | +119.2% | +153.1% |
| EPS (Basic) | $0.63 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.1M | -18.6% | -71.5% |
| Short-term Investments | $4.8M | +55.4% | +80.5% |
| Accounts Receivable | $831K | -34.3% | -5.8% |
| Inventory | $1.5M | -2.1% | +74.5% |
| Current Assets | $8.4M | +10.7% | -21.7% |
| Total Assets |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.9M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $750K | — | — |
| Financing Cash Flow | $6K | — | — |
| Free Cash Flow | -$3.9M | — | — |
| +119.3% |
| +153.4% |
| EPS (Diluted) | $0.62 | +119.0% | +152.5% |
| $8.6M |
| +10.2% |
| -43.7% |
| Current Liabilities | $2.3M | +24.3% | -1.8% |
| Total Liabilities | $3.1M | -3.5% | -38.3% |
| Stockholders' Equity | $5.4M | +20.1% | -47.1% |